Drugs can be administered directly into the body through injections, infusion, or through other drug delivery devices. Drug delivery devices are the devices or formulations used to inject therapeutic substances in the body through a ...
Tags: Devices Market, treatment, Medicine
The medtech jobs picture looked rosy in 2013, with the top 15 device makers in hiring mode, according to an EP Vantage report out this week. Excluding pharmaceutical spinoffs, these companies expanded their collective workforce by 6%, the ...
Tags: Medtech Jobs, Health, Medicine
In honor of its broad-based efforts to improve the lives of the most vulnerable members of its community, Crozer-Keystone Health System in Delaware County, Pa. is the recipient of the 2013 Foster G. McGaw Prize for Excellence in Community ...
Tags: Health, Medicine, Community Service
Baxter International Inc. (NYSE:BAX) today announced completion of CE marking in Europe for the VIVIA hemodialysis (HD) system, designed to deliver more frequent, extended duration, short daily or nocturnal home HD therapy, known as High ...
Baxter International has submitted a biologics license application (BLA) to the US Food and Drug Administration (FDA) for the approval of a recombinant antihemophilic porcine sequence factor VIII called 'OBI-1' for the treatment of patients ...
The largest medical device companies have had a good run on the stock markets this year, with many clocking in double-digit percentage growth in stock prices over the past 12 months. There are always exceptions to the rule, however. Here ...
Tags: Medical Device, Medical Device Firms, Worst Performing Firms
Baxter International has filed an application to the US Food and Drug Administration (FDA) for a pediatric indication for Rixubis [Coagulation Factor IX (Recombinant)] to treat hemophilia B. The submission was based on a Phase II/III ...
Baxter International has filed an amended biologics license application (BLA) to the US Food and Drug Administration (FDA) to re-start the review process for approval of HyQvia facilitated subcutaneous infusion to treat adult patients with ...
Baxter International has initiated a voluntary recall of one lot of Nitroglycerin in 5% Dextrose injection due to particulate matter found in one vial. If infused, particulate matter could lead to potential venous and/or arterial ...
Tags: Dextrose Injection, Medicine
Baxter International has announced the introduction of HEMOPATCH sealing hemostat, a collagen-based resorbable hemostatic device used for surgical procedures when control of bleeding by pressure, ligature or conventional procedures is ...
Baxter International has acquired Flowsense Medical, a portfolio company of Trendlines Group for approximately $9.5m, including liabilities. Flowsense Medical manufactures automated, continuous urine monitor systems. The company's URINFO ...
Tags: Baxter, Flowsense Medical
The Chinese Ministry of Commerce has approved the proposed acquisition of the Swedish dialysis equipment manufacturer Gambro by Baxter International for $4 bn. Under the terms of the conditional approval, the company is supposed to sell ...
Tags: Gambro Buyout, Baxter
LABS, a full-service testing laboratory, has named Ray Swanson as the company's new president and chief executive officer (CEO). Previously, Swanson served as CEO and played general management roles at various companies including Centice, ...
Tags: LABS, Ray Swanson, CEO, chief executive officer, testing laboratory
Baxter International has gained approval for ADVATE [Recombinant Human Coagulation Factor VIII for injection] to treat hemophilia A in China. ADVATE is infused directly into the bloodstream, allowing the body's blood clotting process to ...
Tags: Baxter International, ADVATE, hemophilia A, bleeding episodes
Baxter International has collaborated with Chatham Therapeutics for the development and commercialization of factor IX hemophilia B gene therapy treatment. According to the agreement, the companies will investigate the next generation of ...
Tags: IX hemophilia B gene therapy, Biological Nano Particles, clinical trials